posted on 2017-11-24, 14:39authored byHéctor Carreño Gutiérrez, Aet O'Leary, Florian Freudenberg, Giorgio Fedele, Rob Wilkinson, Eleanor Markham, Freek van Eeden, Andreas Reif, William H. J. Norton
Nitric oxide (NO) is a gaseous neurotransmitter that has important behavioural functions in the vertebrate brain. In this study we compare the impact of decreased nitric NO signalling upon behaviour and neurobiology using both zebrafish and mouse. nitric oxide synthase mutant (nos1(-/-)) zebrafish show significantly reduced aggression and an increase in anxiety-like behaviour without altered production of the stress hormone cortisol. Nos1(-/-) mice also exhibit decreased aggression and are hyperactive in an open field test. Upon reduction of NO signalling, monoamine neurotransmitter metabolism is reduced as a consequence of decreased Monoamine oxidase activity. Treatment of nos1(-/-) zebrafish with the 5-HT receptor 1A agonist 8-OH-DPAT rescues aggression and some aspects of anxiety-like behaviour. Taken together, the interplay between NO and 5-HT appears to be critical to control behaviour. Our cross-species approach challenges the previous notion that reduced neuronal NOS leads to increased aggression. Rather, Nos1 knock-out can also lead to decreased aggression in some situations, a finding that may have implications for future translational research.
Funding
The research leading to these results received funding from the
European Community's Seventh Framework Programme (FP7/2007–
2013) under grant agreement no. 602805. We thank the following
funding agencies for their support: ZF-HEALTH-F4-2010-242048,
MRC Centre grant G0700091 and WT 077544/Z/05/Z (FvE), CoCA
EC Horizon 2020 grant agreement no 667302, the German Research
Foundation (CRC 1193 to AR and FR3420/2-1 to FF) and the EMF
Biological Research Trust, London (GF)
History
Citation
European Neuropsychopharmacology, 2017
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/MBSP Non-Medical Departments/Neuroscience, Psychology and Behaviour
Version
AM (Accepted Manuscript)
Published in
European Neuropsychopharmacology
Publisher
Elsevier for European College of Neuropsychopharmacology
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.;Supplementary data associated with this article can be
found in the online version at doi:10.1016/j.euroneuro.2017.09.004.